GlassScriptPhysician profile
Kishore G Pathial
NPI 1396765236
$8,044.03
in general payments reported to CMS, 2019-2025
41 companies · $1,497 in 2025
The $1,497 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,160 · 2020: $953 · 2021: $1,140 · 2022: $902 · 2023: $1,320 · 2024: $1,071 · 2025: $1,497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,631 · Education: $257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,631.09 |
| Education | $256.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,390.68 | 2019-2025 | Airsupra, Breztri, Fasenra |
| Grifols USA, LLC | $1,118.21 | 2019-2025 | Prolastin-C Liquid |
| Glaxosmithkline, LLC. | $989.16 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $659.10 | 2019-2025 | Ofev, Jascayd |
| Genzyme Corporation | $365.83 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $353.47 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $288.24 | 2020-2023 | Glassia |
| Actelion Pharmaceuticals US, INC. | $268.52 | 2019-2024 | Opsumit, Uptravi |
| Mylan Specialty L.P. | $249.86 | 2019-2023 | Yupelri |
| Harmony Biosciences LLC | $199.12 | 2022-2025 | Wakix |
| Regeneron Healthcare Solutions, INC. | $182.14 | 2019-2024 | Dupixent |
| Amgen INC. | $158.19 | 2021-2025 | Tezspire |
| Sunovion Pharmaceuticals INC. | $156.68 | 2019-2021 | |
| Genentech USA, INC. | $143.93 | 2019-2021 | |
| Electromed, INC. | $140.67 | 2021-2024 | Smartvest |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $126.92 | 2019-2023 | |
| Jazz Pharmaceuticals INC. | $116.18 | 2019-2023 | |
| Insmed, INC. | $98.01 | 2020-2025 | Arikayce |
| Verona Pharma, INC. | $96.90 | 2025 | Ohtuvayre |
| United Therapeutics Corporation | $85.66 | 2022-2024 | Tyvaso |
| Baxter Healthcare | $82.32 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Synclara Cough System, Hillrom - Life 2000 Ventilation System |
| Axsome Therapeutics, INC. | $75.42 | 2023-2025 | Sunosi |
| Shire North American Group INC | $69.87 | 2019 | |
| Philips North America LLC | $64.94 | 2019-2023 | |
| Viatris Specialty LLC | $62.88 | 2025 | Yupelri |
| Inspire Medical Systems, INC. | $58.40 | 2025 | Inspire |
| Teva Pharmaceuticals USA, INC. | $49.99 | 2020 | |
| Lilly USA, LLC | $48.11 | 2025 | Zepbound |
| Edwards Lifesciences Corporation | $44.86 | 2025 | Sapien 3 Ultra Resilia |
| Fisher & Paykel Healthcare INC | $43.28 | 2023-2024 | Fisher & Paykel Healthcare |
| Circassia INC. | $42.01 | 2019 | |
| Merck Sharp & Dohme LLC | $35.13 | 2022-2023 | |
| Itamar Medical INC | $26.67 | 2024 | Watchpatone |
| Sentec, INC. | $26.22 | 2025 | |
| Apria Healthcare LLC | $22.53 | 2021 | |
| Avadel Cns Pharmaceuticals, LLC | $22.29 | 2025 | Lumryz |
| Zoll Respicardia, INC. | $16.96 | 2023 | Remede System |
| Vanda Pharmaceuticals INC. | $16.95 | 2021 | |
| Gilead Sciences, INC. | $16.37 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.72 | 2020 | |
| Tactile Systems Technology INC | $15.64 | 2025 | Nimbl, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kishore Pathial listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.